Health Canada(HC)
Canada's federal department responsible for regulating drugs, medical devices, and other health products.
Usage Examples
- Health Canada issued a Notice of Compliance.
- The NDS was submitted to HPFB.
- Canadian labeling requirements differ from FDA.
What is HC?
Health Canada is the federal department responsible for helping Canadians maintain and improve their health. The Health Products and Food Branch (HPFB) regulates pharmaceutical drugs, medical devices, natural health products, and other health products.
Drug submissions include New Drug Submissions (NDS) for innovative drugs and Abbreviated New Drug Submissions (ANDS) for generics. The regulatory framework is based on the Food and Drugs Act and regulations.
Health Canada participates in ICH and recognizes foreign reviews in some cases. The Project Orbis initiative enables concurrent review with FDA and other agencies for oncology products.
Regulatory Context
This term appears most often in general workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside FOOD AND DRUGS ACT, HEALTH CANADA REGULATIONS.
When This Matters
- Health Canada issued a Notice of Compliance.
- The NDS was submitted to HPFB.
- Canadian labeling requirements differ from FDA.
Common Mistakes
- Relying on generic terminology without mapping to the active jurisdiction context.
- Skipping cross-links between terms, tools, and active regulatory references.
- Failing to maintain a single source of truth for regulatory definitions internally.
Related Regulations
Frequently Asked Questions
A Notice of Compliance (NOC) is Health Canada's authorization to market a drug in Canada, equivalent to FDA approval. It's issued after successful review of the drug submission.
Health Canada reviews submissions independently but may leverage foreign reviews. Certain initiatives like Project Orbis enable coordinated reviews. Canadian-specific requirements may still apply.
Related Terms
Related Use Cases
Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
Cut regulatory intelligence tracking from 10+ hours/week to automated, real-time alerts
Track GxP regulation changes and enforcement trends
Related Regulatory Intelligence
Related Actions
Sources & References

